BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33489015)

  • 21. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
    Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
    Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss.
    Lin L; Wang H; Guo W; He E; Huang K; Zhao Q
    Cell Signal; 2021 Jun; 82():109935. PubMed ID: 33529755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-31a-5p from aging BMSCs links bone formation and resorption in the aged bone marrow microenvironment.
    Xu R; Shen X; Si Y; Fu Y; Zhu W; Xiao T; Fu Z; Zhang P; Cheng J; Jiang H
    Aging Cell; 2018 Aug; 17(4):e12794. PubMed ID: 29896785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183.
    Guo J; Duan Z; Zhang C; Wang W; He H; Liu Y; Wu P; Wang S; Song M; Chen H; Chen C; Si Q; Xiang R; Luo Y
    J Immunol; 2020 Nov; 205(10):2916-2925. PubMed ID: 32989094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-196b-5p Regulates Osteoblast and Osteoclast Differentiation and Bone Homeostasis by Targeting SEMA3A.
    Xie Y; Zhou J; Tian L; Dong Y; Yuan H; Zhu E; Li X; Wang B
    J Bone Miner Res; 2023 Aug; 38(8):1175-1191. PubMed ID: 37221130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
    Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
    Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes from LSD1 knockdown breast cancer cells activate osteoclastogenesis and inhibit osteoblastogenesis.
    Liu Z; Zhang N; Xin B; Shi Y; Liang Z; Wan Y; Hu X
    Int J Biol Macromol; 2023 Apr; 235():123792. PubMed ID: 36828097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation.
    Han Z; Zhan R; Chen S; Deng J; Shi J; Wang W
    J Cell Biochem; 2020 Feb; 121(2):1664-1674. PubMed ID: 31680294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
    Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
    FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2.
    Hu L; Xie X; Xue H; Wang T; Panayi AC; Lin Z; Xiong Y; Cao F; Yan C; Chen L; Cheng P; Zha K; Sun Y; Liu G; Yu C; Hu Y; Tao R; Zhou W; Mi B; Liu G
    Exp Mol Med; 2022 Jul; 54(7):961-972. PubMed ID: 35831436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-92a-3p encapsulated in bone metastatic mammary tumor cell-derived extracellular vesicles modulates mature osteoclast longevity.
    Uehara N; Kyumoto-Nakamura Y; Mikami Y; Hayatsu M; Sonoda S; Yamaza T; Kukita A; Kukita T
    Cancer Sci; 2022 Dec; 113(12):4219-4229. PubMed ID: 36053115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
    Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
    Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system.
    Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH
    Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
    Morrissey C; Lai JS; Brown LG; Wang YC; Roudier MP; Coleman IM; Gulati R; Vakar-Lopez F; True LD; Corey E; Nelson PS; Vessella RL
    Prostate; 2010 Mar; 70(4):412-24. PubMed ID: 19866469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.
    Pagel CN; Kularathna PK; Sanaei R; Young ND; Hooper JD; Mackie EJ
    Prostate; 2022 May; 82(6):723-739. PubMed ID: 35167724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.